您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[财报]:贝泰妮:云南贝泰妮生物科技集团股份有限公司2023年年度报告_英文版 - 发现报告
当前位置:首页/财报/招股书/报告详情/

贝泰妮:云南贝泰妮生物科技集团股份有限公司2023年年度报告_英文版

2024-04-26财报-
贝泰妮:云南贝泰妮生物科技集团股份有限公司2023年年度报告_英文版

YunnanBotaneeBio-TechnologyGroupCo.,Ltd. 2023AnnualReport 2024-011 April,2024 2023AnnualReport SectionIImportantNotice,TableofContents,andDefinitions OurBoardofDirectors,BoardofSupervisors,directors,supervisors,andseniormanagersguaranteethatthisannualreportistrue,accurateandcompletewithoutfalsehoods,misleadingstatementsormajoromissions,andundertakeindividualandjointlegalliabilitiesarisingtherefrom. OurChairmanandPresidentMr.GuoZhenyu,CFOMr.WangLong,andHeadofAccountingDepartmentMr.LiuZhaofengherebydeclarethatthefinancialstatementshereinaretrue,accurate,andcomplete. AlldirectorsofBotaneehaveattendedtheboardmeetingfordeliberatingonthisreport. Forward-lookingstatementshereinonBotanee’sfutureprospects,businessplans,etc.donotconstitutesubstantialcommitmentstoinvestors.Investorsareadvisedtoreadcarefullysuchinformation,andwatchinvestmentrisks.Investorsandrelatedpartiesshouldmaintainadequateriskawareness,andunderstandthedifferencesbetweenplans,forecasts,andcommitments. Wehavedescribedindetailpossiblerisksinouroperationsandourcountermeasuresin“SectionIIIManagementDiscussionandAnalysis”and“SectionXIFutureProspectsofBotanee”ofthisreport.Investorsarekindlyrequestedtopayattentiontothesesections. Ourprofit-sharingplandeliberatedonandadoptedbytheBoardofDirectorsis:todistributeCNY6.00ofcashdividendforevery10sharestoallshareholdersbasedon420,605,382shares,givethem0bonusshares(taxincluded),andissue0sharesforthemforevery10sharesbytransferringcapitalreserve. TableofContents SectionIImportantNotice,TableofContents,andDefinitions2 SectionIICompanyProfileandKeyFinancialIndicators10 SectionIIIDiscussionandAnalysisbytheManagement15 SectionIVCorporateGovernance60 SectionVEnvironmentalandSocialResponsibility81 SectionVISignificantEvents82 SectionVIIChangesinSharesandInformationaboutShareholders111 SectionIVShareRepurchasesduringtheReportingPeriod115 SectionVIIIPreferenceShares117 SectionIXBonds118 SectionXFinancialReport119 DocumentsAvailableforInspection (1)Theoriginalofour2023AnnualReportsignedbytheCompany’slegalrepresentativeMr.GuoZhenyu. (2)ThefinancialstatementssignedandsealedbytheCompany’slegalrepresentativeMr.GuoZhenyu,CFOMr.WangLong,andHeadofAccountingDepartmentMr.LiuZhaofeng,thepersoninchargeoftheaccountingfirm(AccountingSupervisor). (3)TheoriginalofourauditreportsealedbyTalentCertifiedPublicAccountants(SpecialGeneralPartnership),andsignedandsealedbyitscertifiedpublicaccountants. 4)Theoriginalofallourdocumentsandannouncementsthathavebeenpubliclydisclosedduringthereportingperiod.TheabovedocumentsarekeptatourBoardSecretary’sOffice. Definitions Term Definition CSRC ChinaSecuritiesRegulatoryCommission SZSE ShenzhenStockExchange TheCompany/Botanee YunnanBotaneeBio-TechnologyGroupCo.,Ltd. BotaneeCo.,Ltd. KunmingBotaneeBio-TechnologyCo.,Ltd.,thepredecessorofBotanee ShanghaiBotanee ShanghaiBotaneeBio-TechnologyCo.,Ltd.,awholly-ownedsubsidiaryofBotanee Beixiaoni(Shanghai) Beixiaoni(Shanghai)TechnologyCo.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotanee YanyaoMedicalManagement Yanyao(Shanghai)MedicalManagementCo.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotanee YanyaoMedicalBeauty ShanghaiYanyaoMedicalBeautyClinicCo.,Ltd.,awholly-ownedsubsidiaryofYanyaoMedicalManagement Botanee(Xiamen) Botanee(Xiamen)TechnologyCo.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotanee Botanee(Hangzhou) Botanee(Hangzhou)TechnologyCo.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotanee Botanee(Hainan) Botanee(Hainan)E-commerceCo.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotanee ChengduBotanee ChengduBotaneeEnterpriseManagementCo.,Ltd.,awholly-ownedsubsidiaryofBotanee SichuanBotanee SichuanBotaneeBio-TechnologyCo.,Ltd.,aholdingsubsidiaryofChengduBotanee WuhouBotanee ChengduWuhouBotaneeBio-TechnologyCo.,Ltd.,awholly-ownedsubsidiaryofSichuanBotanee WuhanBotanee WuhanBotaneeBio-TechnologyCo.,Ltd.,aholdingsubsidiaryofBotanee KunmingBotaneeSales KunmingBotaneeBio-TechnologySalesCo.,Ltd.,awholly-ownedsubsidiaryofBotanee KunmingYunzhuang KunmingYunzhuangBiotechnologyCo.,Ltd.,awholly-ownedsubsidiaryofBotanee KunmingWinona KunmingWinonaSkincareCo.,Ltd.,aholdingsubsidiaryofWinonaYunzhuang QiumeiTechnology(Shanghai) QiumeiTechnology(Shanghai)Co.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotanee QiumeiTechnology(Kunming) QiumeiTechnology(Kunming)Co.,Ltd.,awholly-ownedsubsidiaryofBotanee ShanghaiBotaneeTechnology ShanghaiBotaneeHealthTechnologyCo.,Ltd.,awholly-ownedsubsidiaryofBotanee ShanghaiJiyanBiomedical ShanghaiJiyanBiomedicalDevelopmentCo.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotaneeTechnology Botanee(Shanghai)SupplyChain Botanee(Shanghai)SupplyChainManagementCo.,Ltd.,awholly-ownedsubsidiaryofShanghaiBotaneeTechnology Botanee(Kunming)Trading Botanee(Kunming)TradingCo.,Ltd.,awholly-ownedsubsidiaryofBotanee BotaneeTrading BotaneeTradingCo.,Ltd.,awholly-ownedsubsidiaryofBotanee YunnanYunke YunnanYunkeSpecialtyPlantExtractionLaboratoryCo.,Ltd.,awholly-ownedsubsidiaryofBotanee ShanghaiYibeini ShanghaiYibeiniHealthTechnologyCo.,Ltd.,awholly-ownedsubsidiaryofBotanee Aoxmed(Shanghai) Aoxmed(Sh